American Society of Hematology

Fig. 7.

$Fig. 7. Expression of individual alleles in a patient with refractory lymphoma over time. The MDR-1 level determined by quantitative PCR as well the percent of normal and malignant cells in the biopsies are tabulated. Over time, the patient was treated with multiple regimens, all of which contained “MDR-1 drugs.”$

Expression of individual alleles in a patient with refractory lymphoma over time. The MDR-1 level determined by quantitative PCR as well the percent of normal and malignant cells in the biopsies are tabulated. Over time, the patient was treated with multiple regimens, all of which contained “MDR-1 drugs.”

This Feature Is Available To Subscribers Only